News
Discover a recent study that found that microultrasonography-guided biopsy could provide an alternative to MRI.
6d
News-Medical.Net on MSNGenetic test outperforms PSA and MRI in spotting deadly prostate cancer earlyA UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...
A new study from Sunnybrook Health Sciences Centre and the University of Toronto has shown that high-resolution ultrasound is ...
"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...
Use of NeuroSAFE during prostatectomy nearly doubled the number of patients who had no or mild erectile dysfunction ...
7d
MedPage Today on MSNPolygenic Risk Tool Can Detect Clinically Significant Prostate CancersFor men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have ...
Of these 745 participants, 468 (62.8%) underwent MRI and prostate biopsy; prostate cancer was detected in 187 participants (40.0%). The median age at diagnosis was 64 years (range, 57 to 73).
An at-home saliva test that assesses genetic risk of prostate cancer may be more accurate than PSA level or MRI.
Experts have developed a simple saliva test which analyses genetic variants in a man's DNA which appears to perform better ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results